Literature DB >> 16463655

Changes of monophasic action potential duration and effective refractory period of three layers myocardium of canine during acute ischemia in vivo.

Fanzhi Zhang1, Jiagao Lv, Lin Wang, Jun Pu, Lan Wang.   

Abstract

The effect of acute ischemia on the electrophysiological characteristics of the three layers myocardium of canine in vivo was investigated. Twelve canines were divided into two groups randomly: acute ischemia (AI) group and sham operation (SO) group. By using the monophasic action potential (MAP) technique, MAP and effective refractory period (ERP) of the three layers myocardium were measured by specially designed plunge needle electrodes and the transmural dispersion of repolarization (TDR) and transmural dispersion of ERP (TDE) were analyzed. The results showed that in the AI group, MAP duration (MAPD) was shortened from 201.67 +/- 21.42 ms to 169.50 +/- 13.81 ms (P < 0.05), but ERP prolonged to varying degrees and TDE increased during ischemia. In the SO group, MAPD and ERP did not change almost. Among of the three layers myocardium of canine, MAPD was coincident in two groups. It was concluded that during acute ischemia, MAPD was shortened sharply, but there was no significant difference among of the three layers myocardium. The prolonged ERP was concomitant with increased TDE during acute ischemia, which may play an important role in the occurrence of arrhythmias induced by acute ischemia. These findings may have important implications in arrhythmogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16463655     DOI: 10.1007/BF02895998

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

Review 1.  Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy.

Authors:  R Wolk; S M Cobbe; M N Hicks; K A Kane
Journal:  Pharmacol Ther       Date:  1999-11       Impact factor: 12.310

Review 2.  Dispersion of ventricular repolarization and refractory period.

Authors:  F L Burton; S M Cobbe
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

Review 3.  The controversial M cell.

Authors:  E P Anyukhovsky; E A Sosunov; R Z Gainullin; M R Rosen
Journal:  J Cardiovasc Electrophysiol       Date:  1999-02

4.  A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell.

Authors:  S Sicouri; C Antzelevitch
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

5.  Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations.

Authors:  E P Anyukhovsky; E A Sosunov; M R Rosen
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

6.  Ventricular arrhythmias in the subacute myocardial infarction period. High-resolution activation and refractory patterns of reentrant rhythms.

Authors:  M Restivo; W B Gough; N el-Sherif
Journal:  Circ Res       Date:  1990-05       Impact factor: 17.367

Review 7.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.

Authors:  M J Janse; A L Wit
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

8.  Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia.

Authors:  P Taggart; P M Sutton; T Opthof; R Coronel; R Trimlett; W Pugsley; P Kallis
Journal:  Cardiovasc Res       Date:  2001-06       Impact factor: 10.787

9.  Transmural reentry triggered by epicardial stimulation during acute ischemia in canine ventricular muscle.

Authors:  Jiashin Wu; Douglas P Zipes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

10.  Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells.

Authors:  E Drouin; F Charpentier; C Gauthier; K Laurent; H Le Marec
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.